|
Volumn 14, Issue 9, 2001, Pages 1259-1265
|
Molecular requirements for inhibition of cytochrome P450 activities by roquefortine
c
CEA SACLAY
(France)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BENZPHETAMINE;
BROMOCRIPTINE;
CYCLOPEPTIDE;
CYTOCHROME P450;
CYTOCHROME P450 1A1;
CYTOCHROME P450 1A2;
CYTOCHROME P450 2D6;
CYTOCHROME P450 3A4;
DEXAMETHASONE;
HEME;
IMIDAZOLE;
PHENOBARBITAL;
PIPERAZINEDIONE;
REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE;
ROQUEFORTINE;
TESTOSTERONE;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ARTICLE;
BACTERIAL GROWTH;
CONTROLLED STUDY;
ENZYME ACTIVITY;
ENZYME INHIBITION;
GROWTH INHIBITION;
HUMAN;
HUMAN CELL;
LIVER MICROSOME;
METABOLITE;
MOLECULAR INTERACTION;
NEUROTOXICITY;
NONHUMAN;
PENICILLIUM;
ULTRAVIOLET RADIATION;
ANIMALS;
ANTI-INFLAMMATORY AGENTS;
CYTOCHROME P-450 ENZYME SYSTEM;
DEXAMETHASONE;
ERGOLINES;
HEME;
HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS;
HUMANS;
INDOLES;
LIVER;
MALE;
PIPERAZINES;
RATS;
RATS, SPRAGUE-DAWLEY;
SPECTRUM ANALYSIS;
TESTOSTERONE;
|
EID: 0034803268
PISSN: 0893228X
EISSN: None
Source Type: Journal
DOI: 10.1021/tx015512l Document Type: Article |
Times cited : (41)
|
References (32)
|